General Information of Drug Transporter (DT)
DT ID DTD0258 Transporter Info
Gene Name SLC2A3
Transporter Name Glucose transporter type 3, brain
Gene ID
6515
UniProt ID
P11169

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        CREB1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in brain neuroblastoma condition [1]

TF Protein Name

Cyclic AMP-responsive element-binding protein 1 Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Brain neuroblastoma [ICD11: 2A00.11]

Tissue

Brain

Related DT Changes

up regulating

Experimental Material

Human neuroblastoma cells (SH-SY5Y)

Detailed Description

Cyclic AMP-responsive element-binding protein 1 (CREB1), influenced by the exogenous estradiol, has been reported to activate the transcription of SLC2A3 gene in brain neuroblastoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 3.

        JUND 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

Transcription factor JunD Transcription Factor Info

Tissue

Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor JunD (JUND) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 6 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC2A3 gene in teratocarcinoma condition [3]

TF Protein Name

Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Teratocarcinoma [ICD11: 2C12.0Y]

Tissue

Embryo

Related DT Changes

Down regulating

Experimental Material

Mouse teratocarcinoma cells (P19)

Detailed Description

Aryl hydrocarbon receptor (AHR) has been reported to repress the transcription of SLC2A3 gene in teratocarcinoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3.

        HIF1A 

Click to Show/Hide to Show 3 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in glioblastoma condition [4]

TF Protein Name

Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

Lactate; Pyruvate

Studied Phenotype

Glioblastoma [ICD11: 2A00.00]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

Human glioblastoma cells (U-87)

Detailed Description

Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in glioblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

       Transcriptional Phenomenon 2

Activation of SLC2A3 gene in health condition [5]

TF Protein Name

Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Knee

Related DT Changes

Up regulating

Experimental Material

C57BL/6 mice

Detailed Description

Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

       Transcriptional Phenomenon 3

Activation of SLC2A3 gene in gestational choriocarcinoma condition [6]

TF Protein Name

Hypoxia-inducible factor 1-alpha Transcription Factor Info

Studied Phenotype

Gestational choriocarcinoma [ICD11: 2C75]

Tissue

Trophoderm

Related DT Changes

Up regulating

Experimental Material

Human gestational choriocarcinoma cells (BeWo)

Detailed Description

Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in gestational choriocarcinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

        TCF12 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [7]

TF Protein Name

Transcription factor 12 Transcription Factor Info

Tissue

Brain; Embryo

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor 12 (TCF12) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        TCF3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Transcription factor E2-alpha Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor E2-alpha (TCF3) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        TFAP4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

Transcription factor AP-4 Transcription Factor Info

Tissue

Blood; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-4 (TFAP4) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        TWIST1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in health condition [10]

TF Protein Name

Twist-related protein 1 Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Heallth [ICD11: N.A]

Tissue

Kidney

Related DT Changes

Up regulating

Experimental Material

Human kidney human embryonic kidney 293T cells (HEK 293T)

Detailed Description

Twist-related protein 1 (TWIST1) has been reported to activate the transcription of SLC2A3 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

      Class 1.3: Basic helix-span-helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        TFAP2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Transcription factor AP-2-alpha Transcription Factor Info

Tissue

Breast

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        TFAP2C 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

Transcription factor AP-2 gamma Transcription Factor Info

Tissue

Breast; Skin

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NR3C1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC2A3 gene in pregnancy condition [11]

TF Protein Name

Glucocorticoid receptor Transcription Factor Info

Studied Phenotype

Pregnancy [ICD11: JA00-JA2Z]

Tissue

Trophoderm

Related DT Changes

Down regulating

Experimental Material

human mononucleated trophoblast cell isolates

Detailed Description

Glucocorticoid receptor (NR3C1) has been reported to repress the transcription of SLC2A3 gene in pregnancy condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3.

      Class 2.2: Other C4 zinc finger-type factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        GATA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [7]

TF Protein Name

Erythroid transcription factor Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Erythroid transcription factor (GATA1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        GATA4 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Transcription factor GATA-4 Transcription Factor Info

Tissue

Heart

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription factor GATA-4 (GATA4) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 7 TF(s) Regulating This DT

        CTCF 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

Transcriptional repressor CTCF Transcription Factor Info

Tissue

Brain

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional repressor CTCF (CTCF) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        MAZ 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

Myc-associated zinc finger protein Transcription Factor Info

Tissue

Blood; Bone marrow; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        SP1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC2A3 gene in brain neuroblastoma condition [12]

TF Protein Name

Transcription factor Sp1 Transcription Factor Info

Studied Phenotype

Brain neuroblastoma [ICD11: 2A00.11]

Tissue

Brain

Related DT Changes

Down regulating

Experimental Material

Mouse neuroblastoma cells (neuro-2a)

Detailed Description

Transcription factor Sp1 (SP1) has been reported to repress the transcription of SLC2A3 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3.

        SP3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in brain neuroblastoma condition [12]

TF Protein Name

Transcription factor Sp3 Transcription Factor Info

Studied Phenotype

Brain neuroblastoma [ICD11: 2A00.11]

Tissue

Brain

Related DT Changes

Up regulating

Experimental Material

Mouse neuroblastoma cells (neuro-2a)

Detailed Description

Transcription factor Sp3 (SP3) has been reported to activate the transcription of SLC2A3 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

        YY1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in colon cancer condition [13]

TF Protein Name

Transcriptional repressor protein YY1 Transcription Factor Info

Studied Phenotype

Colon cancer [ICD11: 2B90]

Tissue

Colon

Related DT Changes

up regulating

Experimental Material

Human colon carcinoma isolates

Detailed Description

Transcriptional repressor protein YY1 (YY1), influenced by the exogenous oxaliplatin, has been reported to activate the transcription of SLC2A3 gene in colon cancer condition , which leads to an increased expression of the drug transporter Glucose transporter type 3.

        ZBTB7A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Repression of SLC2A3 gene in colon cancer condition [14]

TF Protein Name

Zinc finger and BTB domain-containing protein 7A Transcription Factor Info

Affected Drug/Substrate

Glucose

Studied Phenotype

Colon cancer [ICD11: 2B90]

Tissue

Colon

Related DT Changes

Down regulating

Experimental Material

Human colon adenocarcinoma cells (SW48)

Detailed Description

Zinc finger and BTB domain-containing protein 7A (ZBTB7A) has been reported to repress the transcription of SLC2A3 gene in colon cancer condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3.

        ZNF384 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

Zinc finger protein 384 Transcription Factor Info

Tissue

Blood; Bone marrow

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Zinc finger protein 384 (ZNF384) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        POU2F1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

POU domain, class 2, transcription factor 1 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        FOXA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [7]

TF Protein Name

Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Tissue

Breast; Embryo; Liver; Lung; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        FOXP1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Forkhead box protein P1 Transcription Factor Info

Tissue

Embryo; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Forkhead box protein P1 (FOXP1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 3.5: Tryptophan cluster factors

Click to Show/Hide the Full List of 4 TF(s) Regulating This DT

        FLI1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [7]

TF Protein Name

Friend leukemia integration 1 transcription factor Transcription Factor Info

Tissue

Blood; Vein

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        GABPA 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

GA-binding protein alpha chain Transcription Factor Info

Tissue

Blood; Liver; Prostate

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

GA-binding protein alpha chain (GABPA) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        IRF1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Interferon regulatory factor 1 Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Interferon regulatory factor 1 (IRF1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

        MYB 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

Transcriptional activator Myb Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcriptional activator Myb (MYB) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 3.7: ARID domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        ARID3A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

AT-rich interactive domain-containing protein 3A Transcription Factor Info

Tissue

Bone marrow; Liver

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

TF Superclass 6: Immunoglobulin fold

      Class 6.4: Runt domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        RUNX1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [7]

TF Protein Name

Runt-related transcription factor 1 Transcription Factor Info

Tissue

Blood; Bone; Bone marrow; Umbilical cord blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Runt-related transcription factor 1 (RUNX1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

      Class 6.7: Grainyhead domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GRHL2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [8]

TF Protein Name

Grainyhead-like protein 2 homolog Transcription Factor Info

Tissue

Breast; Bronchus; Ovary

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

TF Superclass 7: beta-Hairpin exposed by an alpha/beta-scaffold

      Class 7.1: SMAD/NF-1 DNA-binding domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NFIC 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [2]

TF Protein Name

Nuclear factor 1 C-type Transcription Factor Info

Tissue

Blood

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Nuclear factor 1 C-type (NFIC) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.

TF Superclass 8: beta-Sheet binding to DNA

      Class 8.2: A.T hook factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        HMGA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Activation of SLC2A3 gene in colon cancer condition [15]

TF Protein Name

High mobility group protein HMG-I/HMG-Y Transcription Factor Info

Studied Phenotype

Colon cancer [ICD11: 2B90]

Tissue

Colon

Related DT Changes

Up regulating

Experimental Material

human colon cancer cell isolates

Detailed Description

High mobility group protein HMG-I/HMG-Y (HMGA1) has been reported to activate the transcription of SLC2A3 gene in colon cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 3.

TF Superclass 10: Yet undefined DNA-binding domains

      Class 10.1: Other factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        GTF2B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

Direct binding to SLC2A3 gene [9]

TF Protein Name

Transcription initiation factor IIB Transcription Factor Info

Tissue

Cervix; Lung

Related DT Changes

Direct regulating

Experiment method

TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

Transcription initiation factor IIB (GTF2B) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3.
References
1 Akt and cAMP response element binding protein mediate 17beta-estradiol regulation of glucose transporter 3 expression in human SH-SY5Y neuroblastoma cell line. Neurosci Lett. 2015 Sep 14;604:58-63.; 2015 Sep 14;604:58-63.
2 Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
3 Dioxin affects glucose transport via the arylhydrocarbon receptor signal cascade in pluripotent embryonic carcinoma cells. Endocrinology. 2007 Dec;148(12):5902-12.
4 Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem. 2002 Jun 28;277(26):23111-5.
5 Hypoxia regulation of facilitated glucose transporter-1 and glucose transporter-3 in mouse chondrocytes mediated by HIF-1alpha. Joint Bone Spine. 2008 Mar;75(2):176-81.
6 Hypoxic upregulation of glucose transporters in BeWo choriocarcinoma cells is mediated by hypoxia-inducible factor-1. Am J Physiol Cell Physiol. 2007 Jul;293(1):C477-85.
7 The Encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018 Jan 4;46(D1):D794-D801
8 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-151. (ID:ENSG00000059804)
9 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
10 Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro. In Vitro Cell Dev Biol Anim. 2021 Dec;57(10):933-943.
11 Placental glucose transporter expression is regulated by glucocorticoids. J Clin Endocrinol Metab. 1999 Apr;84(4):1445-52.
12 Sp1 and Sp3 regulate transcriptional activity of the facilitative glucose transporter isoform-3 gene in mammalian neuroblasts and trophoblasts. J Biol Chem. 1998 Oct 16;273(42):27474-83.
13 Yin Yang 1 promotes the Warburg effect and tumorigenesis via glucose transporter GLUT3. Cancer Sci. 2018 Aug;109(8):2423-2434.; 2018 Aug;109(8):2423-2434.
14 ZBTB7A acts as a tumor suppressor through the transcriptional repression of glycolysis. Genes Dev. 2014 Sep 1;28(17):1917-28.
15 Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res. 2012 Aug 15;72(16):4097-109.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.